Background: Costunolide (COS), a naturally occurring sesquiterpene lactone, is
associated with erectile dysfunction, self-harm and depression, while minoxidil rash and dermatitis-like reactions, thereby compromising quality of life. 3 Moreover, alopecia is caused mostly by aberrant cell cycles of hair follicles, which are not specifically targeted by these drugs. Thus, there is a continuous quest for searching novel hair growth-promoting agents with specific molecular targets.
Hair follicles undergo four cell cycle phases: growth (anagen), regression (catagen), rest (telogen), and shedding (exogen). 4 In particular, the onset of anagen phase requires the activation of multipotent epithelial stem cells located in the bulge region, a specialized part of the hair follicle. Adjacent mesenchymal cells (dermal papilla) transmit activation signals and direct multipotent epithelial stem cells to migrate and differentiate into the hair bulb, which ultimately transforms into new hair. 5 Multiple signaling molecules, including
Wnts, Sonic hedgehog (Shh), and TGF-b emanating from adjacent mesenchymal cells, contribute to the anagen initiation of multipotent epithelial stem cells. However, the detailed mechanisms how these signaling molecules coordinate to activate the cell cycle of hair follicles are largely unknown. 6 Targeting these multicomponent signaling of hair growth regulation would be a rational approach for developing novel therapeutics for the treatment of alopecia. Thus, this study has been designed to examine the effects of costunolide (COS), a naturally occurring sesquiterpene lactone, on the proliferation of human hair follicle dermal papilla cells (hHFDPC) as well as the in vivo growth of hair in mice. COS is conventionally used in herbal medicine. Previous studies have demonstrated that COS exhibits anti-inflammatory, 7 antioxidant, 8 and antitumorigenic activities. 9 Our study revealed that COS can stimulate hair growth via modulation of TGF-b, Shh, and WNT/b-catenin signaling pathways and stimulating proliferation of human hair follicle dermal papilla cells (hHFDPC).
| MATERIALS AND METHODS

| Cell culture, chemicals, and antibodies
Human hair follicle dermal papilla cells were purchased from Abm Inc (Richmond, British Columbia, Canada). DMEM and fetal bovine serum (FBS) were acquired from Invitrogen (Carlsbad, CA, USA).
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F I G U R E 1 Effects of COS on hHFDPCs. A, Chemical structures of COS. B, Real-time xCELLigence system and C, CellTiter-Glo â luminescent cell growth assay show that COS promotes proliferation of hHFDPCs. D, Inhibitory effects of COS on the 5a-reductase in hHFDPCs. Each values represent mean AE SE in triplicates. Inhibitory activities of COS on 5a-reductase; inhibition (%) = {1-(sample/ control)} 9 100. The asterisk(s) indicate a significant statistical significance (*P < .05, **P < .01)
HDPCs were cultured in DMEM supplemented with 10% fetal bovine serum (FBS) and 100 U/mL penicillin and 100 U/ml streptomycin. Cells were maintained in 5% CO 2 incubator within a humidi- 
| Measurement of endogenous 5a-reductase enzyme activity
Cells were exposed to COS (3 lmol/L) alone or in combination with testosterone (0.4 lmol/L) for 24 hours. After collection of cell lysates, endogenous 5a-reductase 2 activity was determined using human 3-oxo-5-alpha-steroid 4-dehydrogenase 2(SRD5A2) ELISA Kit (Cusabio Biotech, Wuhan, China).
| RNA isolation and quantitative real-time PCR
After an exposure to COS (0-3 lmol/L) for 48 hours, total RNA from HDPCs was extracted using NucleoSpin â RNA Kit (Macherey-Nagel
Gmbh & Co., D€ uren, Germany). Reverse transcription of total RNA was performed using iScript TM cDNA Synthesis Kit (Bio-Rad, Hercules, CA, USA). Briefly, 2 lg of total RNA was used for cDNA preparation. Synthesized cDNA was further amplified by PCR using 
| Western blotting
After HDPC cells were exposed to COS (0-3 lmol/L) for 48 hours, 
| Measurement of hair growth in mice
Seven-week-old female C57BL6 mice were purchased from Orient Bio Co (Seoul, Korea). After 7-day acclimation in the facility, mice were divided into 2 randomized groups (n = 4) and dorsal hair was shaven by clippers. One group of mice was treated topically with 
| Reconstitution assay
The hair-inductive capacity of the human DP was assessed in accordance with the established reconstitution assay. 10 Implantation was performed as described previously. 11 Briefly, COS-treated mouse dermal cells or COS-treated DP spheres were combined with freshly isolated neonatal mouse epidermal cells and cotransplanted subcutaneously into the skin on the backs of nude mice. Three weeks later, skin samples were excised from the mice and examined to verify hair induction.
3 | RESULTS
| COS promotes the growth of hHFDPCs and inhibits the 5a-reductase activity
In this study, we examined the effects of COS on the growth of hHFDPCs. Tofacitinib was used as a positive control. Our results
show that COS promoted proliferation of hHFDPCs in a time- (Figure 1B) and concentration-dependent ( Figure 1C ) manner. We also examined the inhibitory effect of COS on the activity of 5a-reductase enzyme, which catalyzes the conversion of testosterone to the more potent androgen metabolite dihydrotestosterone. COS exhibited 50 AE 6.3% inhibition of 5a-reductase activity when cotreated with testosterone as compared to testosterone control ( Figure 1D ). 100 DP spheres). C, Total induced hair follicles were counted at each injection site, and data are shown as means AE SD of quadruplicate per experiment from three independent experiments (*P < .05, **P < .01)
| COS affects the expression of genes involved in the hair growth
To investigate the effect of COS on regulatory factors of hair growth, we analyzed transcriptional changes of various genes, using cocious re-entry into the regenerative phase of hair growth. 15, 16 Similarly, Hedgehog(Shh) signaling also mediates b-catenin activity to direct hair follicle morphogenesis and hair cycle initiation, such that constitutive Shh deletion results in the arrest of hair follicle morphogenesis at the bud. Interestingly, the activation of Shh signaling in the hair follicle mediates, at least in part, the anagen-inducing effect exerted by noggin signaling. Accordingly, Shh signaling activity has been shown to be upregulated in hair follicles after noggin treatment, and conversely, noggin anagen-inducing activity has been shown to be abrogated in situ by treatment with anti-Shh antibodies.
In contrast, BMP4 signaling activity downregulates Shh signaling in the hair follicle and thus represents an important upstream effector of Shh during the initiation of the hair growth phase in telogen hair follicles. 17, 18 The results of the current study suggested that COS treatment increased both the level of b-catenin and Gli1 mRNA and proteins levels in the analyzed hHFDPCs, and it is likely that these effects on Wnt and Shh signaling activation contributed to the observed increase in hair follicular cell proliferation (Figure 2 and 3 ). 
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